Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry

Aled Clayton, Jacquelyn Court, H. Navabi, +5

Journal of Immunological Methods

Flow CytometryImmunologyImmunophenotypingAntibody ScreeningExtracellular Microvesicles +7

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

Leszek K. Borysiewicz, Alison Fiander, M. Nimako, +10

The Lancet

VaccinationCervical CancerHuman Papillomavirus VaccinesVaccine TargetImmunology +7

Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials

Lesley Stewart, Kristian Aabo, P I Adnitt, +16

Advanced Ovarian CancerMedicineMetronomic TherapyRandomised Clinical TrialsClinical Trials +8

Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection

Nathalie Chaput, Noël E.C. Schartz, Fabrice André, +13

The Journal of Immunology

Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer

Jonathan A. Ledermann, Allan Hackshaw, Stan Kaye, +12

Journal of Clinical Oncology

Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer

Bharat Jasani, H. Navabi, Malcolm Adams

Vaccine

Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityImmunotherapy +5

A clinical grade poly I:C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro

H. Navabi, Bharat Jasani, Ashley Reece, +5

Vaccine

Cell TherapyCancer ImmunosurveillanceMedicineOptimal Dc MaturationImmunology +10

A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian Cancer

Malcolm Adams, I.J. Kerby, I. Rocker, +3

Acta Oncologica

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

D. Gray Heppner, Tracy Kemp, Brian K. Martin, +34

The Lancet Infectious Diseases

VaccinologyVaccinationVaccine SafetyPhase 1BVaccine Development +7

Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial

H. Navabi, Dawn Croston, Jan A. Hobot, +8

Blood Cells Molecules and Diseases

Tumor BiologyMedicineGynecologyExtracellular MicrovesiclesTumor Targeting +5